Nathalie Théou–Anton

Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer

Sandra Assoun, Nathalie Théou–Anton, Marina Nguenang et al. · Lung Cancer · 2019 · 166 citations · Full text

Cancer Immunosurveillance, Medicine, Immune Checkpoint Inhibitors +9

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors

Jérôme Cros, Olivia Hentic, Vinciane Rebours et al. · Endocrine Related Cancer · 2016 · 105 citations · Full text

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Camille Mehlman, Jacques Cadranel, G. Rousseau-Bussac et al. · Lung Cancer · 2019 · 86 citations · Full text

Tumor Biology, Non-small-cell Lung Cancer, Medicine +11

<i>KIT</i> Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors

Séverine Tabone‐Eglinger, Frédéric Subra, Hiba El Sayadi et al. · Clinical Cancer Research · 2008 · 79 citations

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses

Alice Guyard, Claire Danel, Nathalie Théou–Anton et al. · Respiratory Research · 2017 · 56 citations · Full text